United Therapeutics (UTHR) Misses Q1 EPS by 117c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $536.59 -2.7%
EPS Growth %: +12.6%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.82, $1.17 worse than the analyst estimate of $6.99. Revenue for the quarter came in at $781.5 million versus the consensus estimate of $798.85 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
